These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33685433)

  • 1. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
    Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
    Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased E2F2 predicts poor prognosis in patients with HCC based on TCGA data.
    Zeng Z; Cao Z; Tang Y
    BMC Cancer; 2020 Oct; 20(1):1037. PubMed ID: 33115417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
    Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
    Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
    Wu H; Zhang J
    Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis.
    Fu Y; Sun S; Man X; Kong C
    PeerJ; 2019; 7():e7854. PubMed ID: 31592165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-3614-5p Is a Potential Novel Biomarker for Colorectal Cancer.
    Han L; Sun Y; Lu C; Ma C; Shi J; Sun D
    Front Genet; 2021; 12():666833. PubMed ID: 34127929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CDK5R1 predicts worse prognosis in hepatocellular carcinoma based on TCGA data.
    Zeng Z; Cao Z; Zhang E; Huang H; Tang Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33346796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
    Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
    Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCA8 expression and its clinical relevance in patients with bladder cancer.
    Bi Y; Chen S; Jiang J; Yao J; Wang G; Zhou Q; Li S
    Medicine (Baltimore); 2018 Aug; 97(34):e11899. PubMed ID: 30142792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
    Gao L; Zhao A; Wang X
    Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
    Ren Y; Lv Y; Li T; Jiang Q
    Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
    Wang J; Huang R; Huang Y; Chen Y; Chen F
    Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
    Huang C; Zhao J; Luo C; Zhu Z
    Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
    [No Abstract]   [Full Text] [Related]  

  • 15. Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Gao Y; Qi JC; Li X; Sun JP; Ji H; Li QH
    Oncol Lett; 2020 Jan; 19(1):763-770. PubMed ID: 31897192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma.
    Wu M; Kim KY; Park WC; Ryu HS; Choi SC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
    Transl Oncol; 2020 Dec; 13(12):100861. PubMed ID: 32891902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
    Fan X; Wen J; Bao L; Gao F; Li Y; He D
    Front Genet; 2021; 12():681809. PubMed ID: 35095994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
    Tang M; Liao M; Ai X; He G
    Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunology.
    Hu H; Umair M; Khan SA; Sani AI; Iqbal S; Khalid F; Sultan R; Abdel-Maksoud MA; Mubarak A; Dawoud TM; Malik A; Saleh IA; Al Amri AA; Algarzae NK; Kodous AS; Hameed Y
    Am J Transl Res; 2024; 16(2):432-445. PubMed ID: 38463578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.